Latka logo

Celonis vs Synkrino Biotherapeutics: Revenue, Funding & Team Size Compared

Celonis generates $771M in revenue; Synkrino Biotherapeutics has 2 employees. The table below compares Celonis and Synkrino Biotherapeutics on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.

Celonis vs Synkrino Biotherapeutics compared on revenue, funding, valuation, customers and team size
CompanyCelonis logoCelonisThis companySynkrino Biotherapeutics logoSynkrino Biotherapeutics
Revenue$771MNot disclosed
Valuation$13BNot disclosed
Funding raised$2.4BNot disclosed
Customers500Not disclosed
Team size3.7K2
Cash flow$1Not disclosed
Founded2011Not disclosed
HQMunich, GermanyOakland, United States

Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.

Celonis logo

Celonis at a glance

Celonis generates $771M in revenue with 3.7K employees, headquartered in Munich, Germany.

Revenue
$771M
Valuation
$13B
Funding
$2.4B
Customers
500
Team size
3.7K
Founded
2011

Celonis is a company based in Munich, Germany, that provides a process mining platform that uses artificial intelligence and machine learning to help businesses analyze, visualize, and optimize their processes. The company was founded in…

Synkrino Biotherapeutics logo

Synkrino Biotherapeutics at a glance

Synkrino Biotherapeutics has 2 employees, headquartered in Oakland, United States.

Team size
2

Synkrino's AI, SATIS is a powerful, unbiased discovery system for…

Other Celonis alternatives

Celonis competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.

Celonis vs Synkrino Biotherapeutics: frequently asked questions

How much revenue does Celonis make?

Celonis generates $771M in annual revenue with a team of 3.7K.

How much funding has Celonis raised?

Celonis has raised $2.4B in total funding since it was founded in 2011.